APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pre-Pregnancy Genetic Screening Service

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pre-Pregnancy Genetic Screening Service Market Outlook and Growth Opportunities 2026

Report ID 17421905042 May 2026197 pages

Choose your research edition.

Industry ResearchPre-Pregnancy Genetic Screening Service Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Pre-Pregnancy Genetic Screening Service Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Pre-Pregnancy Genetic Screening Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pre-Pregnancy Genetic Screening Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Pre-Pregnancy Genetic Screening Service Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

The global Pre-Pregnancy Genetic Screening Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pre-Pregnancy Genetic Screening Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pre-Pregnancy Genetic Screening Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pre-Pregnancy Genetic Screening Service market include Invitae, Natera, Fulgent Genetics, Myriad Genetics, Quest Diagnostics, LabCorp, GeneDx, Vitrolife and Illumina, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pre-Pregnancy Genetic Screening Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pre-Pregnancy Genetic Screening Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pre-Pregnancy Genetic Screening Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pre-Pregnancy Genetic Screening Service market.

Pre-Pregnancy Genetic Screening Service Segment by Company

Invitae

Natera

Fulgent Genetics

Myriad Genetics

Quest Diagnostics

LabCorp

GeneDx

Vitrolife

Illumina

BillionToOne

Juno Genetics

MedGenome

23andMe

Sonic Genetics

CEN4GEN

BGI Genomics

Berry Genomics

Anoroad

KingMed Diagnostics

CapitalBio Technology

Pre-Pregnancy Genetic Screening Service Segment by Type

Single Disease Screening

Whole Genome Screening

Pre-Pregnancy Genetic Screening Service Segment by Application

Medical and Health Institutions

Research and Educational Institutions

Others

Pre-Pregnancy Genetic Screening Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pre-Pregnancy Genetic Screening Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pre-Pregnancy Genetic Screening Service key companies, revenue, market share, and recent developments.

3. To split the Pre-Pregnancy Genetic Screening Service breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pre-Pregnancy Genetic Screening Service market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pre-Pregnancy Genetic Screening Service significant trends, drivers, influence factors in global and regions.

6. To analyze Pre-Pregnancy Genetic Screening Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pre-Pregnancy Genetic Screening Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pre-Pregnancy Genetic Screening Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pre-Pregnancy Genetic Screening Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pre-Pregnancy Genetic Screening Service industry.

Chapter 3: Detailed analysis of Pre-Pregnancy Genetic Screening Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pre-Pregnancy Genetic Screening Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pre-Pregnancy Genetic Screening Service in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pre-Pregnancy Genetic Screening Service Industry Trends Table 2. Pre-Pregnancy Genetic Screening Service Industry Drivers Table 3. Pre-Pregnancy Genetic Screening Service Industry Opportunities and Challenges Table 4. Pre-Pregnancy Genetic Screening Service Industry Restraints Table 5. Global Pre-Pregnancy Genetic Screening Service Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pre-Pregnancy Genetic Screening Service Revenue Share by Company (2021-2026) Table 7. Global Pre-Pregnancy Genetic Screening Service Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pre-Pregnancy Genetic Screening Service Key Company Manufacturing Base & Headquarters Table 9. Global Pre-Pregnancy Genetic Screening Service Company, Product Type & Application Table 10. Global Pre-Pregnancy Genetic Screening Service Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pre-Pregnancy Genetic Screening Service by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single Disease Screening Table 15. Significant Companies of Whole Genome Screening Table 16. Global Pre-Pregnancy Genetic Screening Service Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pre-Pregnancy Genetic Screening Service Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pre-Pregnancy Genetic Screening Service Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Type (2021-2026) Table 20. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical and Health Institutions Table 22. Significant Companies of Research and Educational Institutions Table 23. Significant Companies of Others Table 24. Global Pre-Pregnancy Genetic Screening Service Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Pre-Pregnancy Genetic Screening Service Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Pre-Pregnancy Genetic Screening Service Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Application (2021-2026) Table 28. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Application (2027-2032) Table 29. Global Pre-Pregnancy Genetic Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Pre-Pregnancy Genetic Screening Service Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Region (2021-2026) Table 32. Global Pre-Pregnancy Genetic Screening Service Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Region (2027-2032) Table 34. Global Pre-Pregnancy Genetic Screening Service Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pre-Pregnancy Genetic Screening Service Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Pre-Pregnancy Genetic Screening Service Sales Value Market Share by Country (2021-2026) Table 37. Global Pre-Pregnancy Genetic Screening Service Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Pre-Pregnancy Genetic Screening Service Sales Value Market Share by Country (2027-2032) Table 39. Invitae Company Information Table 40. Invitae Business Overview Table 41. Invitae Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio Table 43. Invitae Recent Development Table 44. Natera Company Information Table 45. Natera Business Overview Table 46. Natera Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Natera Pre-Pregnancy Genetic Screening Service Product Portfolio Table 48. Natera Recent Development Table 49. Fulgent Genetics Company Information Table 50. Fulgent Genetics Business Overview Table 51. Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 53. Fulgent Genetics Recent Development Table 54. Myriad Genetics Company Information Table 55. Myriad Genetics Business Overview Table 56. Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 58. Myriad Genetics Recent Development Table 59. Quest Diagnostics Company Information Table 60. Quest Diagnostics Business Overview Table 61. Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 63. Quest Diagnostics Recent Development Table 64. LabCorp Company Information Table 65. LabCorp Business Overview Table 66. LabCorp Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio Table 68. LabCorp Recent Development Table 69. GeneDx Company Information Table 70. GeneDx Business Overview Table 71. GeneDx Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio Table 73. GeneDx Recent Development Table 74. Vitrolife Company Information Table 75. Vitrolife Business Overview Table 76. Vitrolife Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio Table 78. Vitrolife Recent Development Table 79. Illumina Company Information Table 80. Illumina Business Overview Table 81. Illumina Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio Table 83. Illumina Recent Development Table 84. BillionToOne Company Information Table 85. BillionToOne Business Overview Table 86. BillionToOne Pre-Pregnancy Genetic Screening Service Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio Table 88. BillionToOne Recent Development Table 89. Juno Genetics Company Information Table 90. Juno Genetics Business Overview Table 91. Juno Genetics Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 93. Juno Genetics Recent Development Table 94. MedGenome Company Information Table 95. MedGenome Business Overview Table 96. MedGenome Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio Table 98. MedGenome Recent Development Table 99. 23andMe Company Information Table 100. 23andMe Business Overview Table 101. 23andMe Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio Table 103. 23andMe Recent Development Table 104. Sonic Genetics Company Information Table 105. Sonic Genetics Business Overview Table 106. Sonic Genetics Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 108. Sonic Genetics Recent Development Table 109. CEN4GEN Company Information Table 110. CEN4GEN Business Overview Table 111. CEN4GEN Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio Table 113. CEN4GEN Recent Development Table 114. BGI Genomics Company Information Table 115. BGI Genomics Business Overview Table 116. BGI Genomics Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 118. BGI Genomics Recent Development Table 119. Berry Genomics Company Information Table 120. Berry Genomics Business Overview Table 121. Berry Genomics Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 123. Berry Genomics Recent Development Table 124. Anoroad Company Information Table 125. Anoroad Business Overview Table 126. Anoroad Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio Table 128. Anoroad Recent Development Table 129. KingMed Diagnostics Company Information Table 130. KingMed Diagnostics Business Overview Table 131. KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio Table 133. KingMed Diagnostics Recent Development Table 134. CapitalBio Technology Company Information Table 135. CapitalBio Technology Business Overview Table 136. CapitalBio Technology Pre-Pregnancy Genetic Screening Service Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio Table 138. CapitalBio Technology Recent Development Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Pre-Pregnancy Genetic Screening Service Product Image Figure 2. Global Pre-Pregnancy Genetic Screening Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pre-Pregnancy Genetic Screening Service Market Size (2021-2032) & (US$ Million) Figure 4. Global Pre-Pregnancy Genetic Screening Service Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single Disease Screening Image Figure 8. Whole Genome Screening Image Figure 9. Global Pre-Pregnancy Genetic Screening Service Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pre-Pregnancy Genetic Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Type (2021-2032) Figure 12. Medical and Health Institutions Image Figure 13. Research and Educational Institutions Image Figure 14. Others Image Figure 15. Global Pre-Pregnancy Genetic Screening Service Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Pre-Pregnancy Genetic Screening Service Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Application (2021-2032) Figure 18. Global Pre-Pregnancy Genetic Screening Service Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032) & (US$ Million) Figure 21. North America Pre-Pregnancy Genetic Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Pre-Pregnancy Genetic Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Pre-Pregnancy Genetic Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032) & (US$ Million) Figure 27. South America Pre-Pregnancy Genetic Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Pre-Pregnancy Genetic Screening Service Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Single Disease Screening
  • Whole Genome Screening
Applications
  • Medical and Health Institutions
  • Research and Educational Institutions
  • Others
Companies covered
  • Invitae
  • Natera
  • Fulgent Genetics
  • Myriad Genetics
  • Quest Diagnostics
  • LabCorp
  • GeneDx
  • Vitrolife
  • Illumina
  • BillionToOne
  • Juno Genetics
  • MedGenome
  • 23andMe
  • Sonic Genetics
  • CEN4GEN
  • BGI Genomics
  • Berry Genomics
  • Anoroad
  • KingMed Diagnostics
  • CapitalBio Technology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pre-Pregnancy Genetic Screening Service Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pre-Pregnancy Genetic Screening Service Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pre-Pregnancy Genetic Screening Service Market Dynamics
  1. 2.1 Pre-Pregnancy Genetic Screening Service Industry Trends
  2. 2.2 Pre-Pregnancy Genetic Screening Service Industry Drivers
  3. 2.3 Pre-Pregnancy Genetic Screening Service Industry Opportunities and Challenges
  4. 2.4 Pre-Pregnancy Genetic Screening Service Industry Restraints
3 Pre-Pregnancy Genetic Screening Service Market by Company
  1. 3.1 Global Pre-Pregnancy Genetic Screening Service Company Revenue Ranking in 2025
  2. 3.2 Global Pre-Pregnancy Genetic Screening Service Revenue by Company (2021-2026)
  3. 3.3 Global Pre-Pregnancy Genetic Screening Service Company Ranking (2024-2026)
  4. 3.4 Global Pre-Pregnancy Genetic Screening Service Company Manufacturing Base and Headquarters
  5. 3.5 Global Pre-Pregnancy Genetic Screening Service Company Product Type and Application
  6. 3.6 Global Pre-Pregnancy Genetic Screening Service Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pre-Pregnancy Genetic Screening Service Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pre-Pregnancy Genetic Screening Service Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pre-Pregnancy Genetic Screening Service Market by Type
  1. 4.1 Pre-Pregnancy Genetic Screening Service Type Introduction
  2. 4.1.1 Single Disease Screening
  3. 4.1.2 Whole Genome Screening
  4. 4.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Type
  5. 4.2.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Type (2021-2032)
5 Pre-Pregnancy Genetic Screening Service Market by Application
  1. 5.1 Pre-Pregnancy Genetic Screening Service Application Introduction
  2. 5.1.1 Medical and Health Institutions
  3. 5.1.2 Research and Educational Institutions
  4. 5.1.3 Others
  5. 5.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Application
  6. 5.2.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Application (2021-2032)
  8. 5.2.3 Global Pre-Pregnancy Genetic Screening Service Sales Value Share by Application (2021-2032)
6 Pre-Pregnancy Genetic Screening Service Regional Value Analysis
  1. 6.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032)
  7. 6.3.2 North America Pre-Pregnancy Genetic Screening Service Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032)
  10. 6.4.2 Europe Pre-Pregnancy Genetic Screening Service Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pre-Pregnancy Genetic Screening Service Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032)
  16. 6.6.2 South America Pre-Pregnancy Genetic Screening Service Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pre-Pregnancy Genetic Screening Service Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pre-Pregnancy Genetic Screening Service Sales Value Share by Country, 2025 VS 2032
7 Pre-Pregnancy Genetic Screening Service Country-level Value Analysis
  1. 7.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pre-Pregnancy Genetic Screening Service Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pre-Pregnancy Genetic Screening Service Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pre-Pregnancy Genetic Screening Service Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pre-Pregnancy Genetic Screening Service Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pre-Pregnancy Genetic Screening Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Invitae
  2. 8.1.1 Invitae Company Information
  3. 8.1.2 Invitae Business Overview
  4. 8.1.3 Invitae Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Invitae Pre-Pregnancy Genetic Screening Service Product Portfolio
  6. 8.1.5 Invitae Recent Developments
  7. 8.2 Natera
  8. 8.2.1 Natera Company Information
  9. 8.2.2 Natera Business Overview
  10. 8.2.3 Natera Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Natera Pre-Pregnancy Genetic Screening Service Product Portfolio
  12. 8.2.5 Natera Recent Developments
  13. 8.3 Fulgent Genetics
  14. 8.3.1 Fulgent Genetics Company Information
  15. 8.3.2 Fulgent Genetics Business Overview
  16. 8.3.3 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fulgent Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  18. 8.3.5 Fulgent Genetics Recent Developments
  19. 8.4 Myriad Genetics
  20. 8.4.1 Myriad Genetics Company Information
  21. 8.4.2 Myriad Genetics Business Overview
  22. 8.4.3 Myriad Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Myriad Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  24. 8.4.5 Myriad Genetics Recent Developments
  25. 8.5 Quest Diagnostics
  26. 8.5.1 Quest Diagnostics Company Information
  27. 8.5.2 Quest Diagnostics Business Overview
  28. 8.5.3 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Quest Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
  30. 8.5.5 Quest Diagnostics Recent Developments
  31. 8.6 LabCorp
  32. 8.6.1 LabCorp Company Information
  33. 8.6.2 LabCorp Business Overview
  34. 8.6.3 LabCorp Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  35. 8.6.4 LabCorp Pre-Pregnancy Genetic Screening Service Product Portfolio
  36. 8.6.5 LabCorp Recent Developments
  37. 8.7 GeneDx
  38. 8.7.1 GeneDx Company Information
  39. 8.7.2 GeneDx Business Overview
  40. 8.7.3 GeneDx Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GeneDx Pre-Pregnancy Genetic Screening Service Product Portfolio
  42. 8.7.5 GeneDx Recent Developments
  43. 8.8 Vitrolife
  44. 8.8.1 Vitrolife Company Information
  45. 8.8.2 Vitrolife Business Overview
  46. 8.8.3 Vitrolife Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Vitrolife Pre-Pregnancy Genetic Screening Service Product Portfolio
  48. 8.8.5 Vitrolife Recent Developments
  49. 8.9 Illumina
  50. 8.9.1 Illumina Company Information
  51. 8.9.2 Illumina Business Overview
  52. 8.9.3 Illumina Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Illumina Pre-Pregnancy Genetic Screening Service Product Portfolio
  54. 8.9.5 Illumina Recent Developments
  55. 8.10 BillionToOne
  56. 8.10.1 BillionToOne Company Information
  57. 8.10.2 BillionToOne Business Overview
  58. 8.10.3 BillionToOne Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  59. 8.10.4 BillionToOne Pre-Pregnancy Genetic Screening Service Product Portfolio
  60. 8.10.5 BillionToOne Recent Developments
  61. 8.11 Juno Genetics
  62. 8.11.1 Juno Genetics Company Information
  63. 8.11.2 Juno Genetics Business Overview
  64. 8.11.3 Juno Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Juno Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  66. 8.11.5 Juno Genetics Recent Developments
  67. 8.12 MedGenome
  68. 8.12.1 MedGenome Company Information
  69. 8.12.2 MedGenome Business Overview
  70. 8.12.3 MedGenome Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  71. 8.12.4 MedGenome Pre-Pregnancy Genetic Screening Service Product Portfolio
  72. 8.12.5 MedGenome Recent Developments
  73. 8.13 23andMe
  74. 8.13.1 23andMe Company Information
  75. 8.13.2 23andMe Business Overview
  76. 8.13.3 23andMe Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  77. 8.13.4 23andMe Pre-Pregnancy Genetic Screening Service Product Portfolio
  78. 8.13.5 23andMe Recent Developments
  79. 8.14 Sonic Genetics
  80. 8.14.1 Sonic Genetics Company Information
  81. 8.14.2 Sonic Genetics Business Overview
  82. 8.14.3 Sonic Genetics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sonic Genetics Pre-Pregnancy Genetic Screening Service Product Portfolio
  84. 8.14.5 Sonic Genetics Recent Developments
  85. 8.15 CEN4GEN
  86. 8.15.1 CEN4GEN Company Information
  87. 8.15.2 CEN4GEN Business Overview
  88. 8.15.3 CEN4GEN Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  89. 8.15.4 CEN4GEN Pre-Pregnancy Genetic Screening Service Product Portfolio
  90. 8.15.5 CEN4GEN Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 Berry Genomics
  98. 8.17.1 Berry Genomics Company Information
  99. 8.17.2 Berry Genomics Business Overview
  100. 8.17.3 Berry Genomics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Berry Genomics Pre-Pregnancy Genetic Screening Service Product Portfolio
  102. 8.17.5 Berry Genomics Recent Developments
  103. 8.18 Anoroad
  104. 8.18.1 Anoroad Company Information
  105. 8.18.2 Anoroad Business Overview
  106. 8.18.3 Anoroad Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Anoroad Pre-Pregnancy Genetic Screening Service Product Portfolio
  108. 8.18.5 Anoroad Recent Developments
  109. 8.19 KingMed Diagnostics
  110. 8.19.1 KingMed Diagnostics Company Information
  111. 8.19.2 KingMed Diagnostics Business Overview
  112. 8.19.3 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  113. 8.19.4 KingMed Diagnostics Pre-Pregnancy Genetic Screening Service Product Portfolio
  114. 8.19.5 KingMed Diagnostics Recent Developments
  115. 8.20 CapitalBio Technology
  116. 8.20.1 CapitalBio Technology Company Information
  117. 8.20.2 CapitalBio Technology Business Overview
  118. 8.20.3 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Revenue and Gross Margin (2021-2026)
  119. 8.20.4 CapitalBio Technology Pre-Pregnancy Genetic Screening Service Product Portfolio
  120. 8.20.5 CapitalBio Technology Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst